Press release
GLOBAL CAR T CELL THERAPY MARKET TO REACH US$ 8.5 BILLION BY 2028 : CMI
Get Free PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/102
Lately, CAR T cell therapy has emerged as the new pillar for cancer treatment, creating high market potential for companies engaged in development and promotion of the product. Currently, Novartis International AG, Juno Therapeutics and Kite Pharma Inc. are dominating the CAR T cell therapy market. Clinical research by these players have revealed high rate of remission in patients with r/r B cell ALL and DLBCL. These companies are making major investments in R&D to expedite the clinical process. Novartis invested around US$ 9 billion in R&D – significant share of it is allocated towards oncology and development of CAR-T cell products in 2016. This novel cellular immunotherapy has attracted significant investment in last two years.
CAR T cell therapy market is expected to be primarily driven by increasing demand for highly effective therapy mode of treating cancer. Combating cancer has been a major concern for healthcare industry for years. CAR T cell works on gene transfer technology that boosts the immune response of cancer affected individual by destroying affected tumor cells. It has been analyzed to act as a lifesaving drug for over 30 million patients’ sufferings from lymphoma. Though the CAR T cell therapy market outlook is highly optimistic, market players need to address the manufacturing and scalability options to generate higher profits. Novartis and Kite have already started building a roadmap for it.
Key takeaways of the market are:
North America is expected to dominate the CAR T cell therapy market throughout the forecast period. The region is expected to account for 58.3% of overall industry share by 2018. Leukemia, lymphoma, and myeloma accounted for 9.4% of 1.6 million newly diagnosed cancer in 2015. Each year, around 55 thousand people die due to leukemia, lymphoma and myeloma in U.S. Emergence of CAR T cell therapy is expected to address the blood cancer concerns. Mortality rate is expected to be drastically lower by 2020 with the adoption of this novel treatment approach.
Europe is expected to be the second largest market for CAR T cell therapy products manufacturers. Although, the region is expected to create lucrative market opportunities, conducting country-specific clinical trials across Europe is expected to be a cumbersome process for companies and is a key challenge for growth prospects in the region.
To know the latest trends and insights prevalent in this market, click the link below: https://www.coherentmarketinsights.com/market-insight/car-t-cell-therapy-market-102
CD 19 based therapy segment is expected to dominate the global CAR T cell therapy market revenue throughout the forecast period. CD 19 segment is expected to touch a billion dollar mark by 2023. Much of the companies are working on CD 19 to combat leukemia. Other antigens such as CD 20 and CD 22 are also expected to create significant revenue opportunity for treatment of solid tumors.
At present, Novartis International AG and Kite Pharma Inc. are expected to launch their products in 2017. Juno Therapeutics is expected to commercialize its product by 2018. Besides these players, Bellicum Pharmaceutical, Celgene Corporation, and Cellectisare also engaged in R&D process and are focusing on curtailing time-to-market for their product to capitalize the market potential in the following 10 years.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release GLOBAL CAR T CELL THERAPY MARKET TO REACH US$ 8.5 BILLION BY 2028 : CMI here
News-ID: 449678 • Views: …
More Releases from GLOBAL CAR T CELL THERAPY MARKET
Global CAR T Cell Therapy Market, By Targeted Antigen(CD 19,CD 20, GD2, CD22, CD …
CAR T cell therapy has been a major buzzword for a while, owing to its effectiveness in treating blood cancer. These are the genetically engineered receptors that targets surface molecules in patient’s immune system. T cells are collected from patients and are genetically engineered in the laboratory in order to multiply them by millions. These T cells are further injected in patients to offer immunity and guard against recurrence of…
Global CAR T Cell Therapy Market, By Targeted Antigen(CD 19,CD 20, GD2, CD22, CD …
CAR T Cell Therapy Market – A Revolution in Cancer Treatment
Over the last few years, CAR T Cell therapy has gained wide recognition in the healthcare industry. CAR T cell is an innovative technique that involves removal of T Cells from patient’s blood before reinsertion using a genetically altered mechanism. The technology is still in the nascent stage; however, is expected to grow at double digit growth rate creating multi-billion…
Global CAR T Cell Therapy Market, By Targeted Antigen(CD 19,CD 20, GD2, CD22, CD …
CAR T cell therapy has been a major buzzword for a while, owing to its effectiveness in treating blood cancer. These are the genetically engineered receptors that targets surface molecules in patient’s immune system. T cells are collected from patients and are genetically engineered in the laboratory in order to multiply them by millions. These T cells are further injected in patients to offer immunity and guard against recurrence of…
More Releases for Coherent
Micro-LED Market Proving Great Growth | Coherent Market Insights
Micro-LED Market 2021
Micro-LED is a reduced form of LED with a matrix, which provides efficient power, color, brightness and response time. Also known as microLED or mLED. Micro-LED is used for smartphones, tablets, laptops, televisions, smart watches, headsets, and other instantaneous (NTE) devices.
Market Drivers:-
Rising demand for low power and small devices such as Smartphones and smart watches stimulates the growth of the micro-LED market. The growing number of smartphone users…
Petroleum Coke (Petcoke) Market: Business Opportunities - Coherent Market Insigh …
Petroleum coke, also abbreviated as petcoke or coke, is a by-product of crude oil production and is among one category of the group of fossil fuels called combustible substances are known as combustibles. Like other fossil fuels, petroleum coke is subject to a range of environmental concerns including climate change, air pollution, acid rain, and global warming. Many oil & gas corporations are focused on the expansion of their refinery…
Immobilized Trypsin Market Report 2021 - Coherent Market Insights
Immobilized Trypsin Market is created in this intelligence report. This comprehensive research report is a well-thought-out compilation of detailed market development and growth factors optimizing the path of continued growth in terms of exact product data, strategies, and market share of the leading companies in this particular market. We follow an iterative model of research methodology to formulate the report that helps decision-makers make an informed investment appraisal. Literature research…
Ilmenite Market Segments, Share, Trends 2027 | Coherent Market Insights
A detailed report on Global Ilmenite providing a complete information on the current market situation and offering robust insights about the potential size, volume, and dynamics of the market during the forecast period, 2021-2027. The research study offers complete analysis of critical aspects of the global Ilmenite , including competition, segmentation, geographical progress, manufacturing cost analysis, and price structure. We have provided CAGR, value, volume, sales, production, revenue, and…
Bioinformatics Market Outlook Till, 2027 : Coherent Market Insights
The Bioinformatics Market report gives a weighty source to assess the market and other fundamental technicalities identifying with it. The examination unveils the total assessment and veritable parts of the Bioinformatics Market. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data which enhances the understanding, scope and application of this report.The trends and expected prospects for the market…
AI App Development || Coherent Lab LLP
The IT industry is growing day by day and immense popularity. Nowadays, businesses are in search of better opportunities to make money in more innovative way. Considering the AI (artificial intelligence) in mobile and web app development, we at Coherent Lab LLP focuses on developing practical solutions which streamlines to generate more and more profits and smoothen the operations as well.
Situated in the heart of pinkcity, Jaipur, Coherent Lab…
